[CAS NO. 290815-26-8]  Avosentan

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [290815-26-8]

Catalog
AS983111
Brand
Arctom Scientific
CAS
290815-26-8

DESCRIPTION [290815-26-8]

Overview

MDLMFCD22124519
Molecular Weight479.51
Molecular FormulaC23H21N5O5S
SMILESCOC1=C(OC(C(NS(C2=NC=C(C=C2)C)(=O)=O)=NC(C3=CC=NC=C3)=N4)=C4OC)C=CC=C1

For research use only. We do not sell to patients.

Summary

Avosentan(Ro 67-0565; SPP-301) is a potent, selective endothelin receptor(ETA receptor) antagonist. IC50 value: Target: ETA receptor


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT00120328 Speedel Pharma Ltd.
Diabetic Nephropathy
July 2005 Phase 3

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 6.67 mg/mL ( 13.91 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.0855 mL 10.4273 mL 20.8546 mL
5 mM 0.4171 mL 2.0855 mL 4.1709 mL
10 mM 0.2085 mL 1.0427 mL 2.0855 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 0.67 mg/mL (1.40 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 0.67 mg/mL (1.40 mM); Clear solution

* All of the co-solvents are available by MCE.